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Summary The expression of c-myc protein was studied in primary cultures of rat hepatocytes and rat liver-
derived epithelial cell lines. The levels of the protein were determined by flow cytometry using a monoclonal
antibody to the c-myc protein. Freshly isolated hepatocytes from normal adult male Fischer F344 rats had
low but detectable levels of the protein which were similar in the different ploidies. Higher levels were
detected in immortalised but untransformed rat liver cell lines, and increased expression was observed during
passage through the cell cycle. Following in vitro transformation of one of the immortalised epithelial cell
lines by ras genes, similar levels of c-myc expression to those present in the untransformed cells was
maintained. Transformation by activated aflatoxin B1 (AFB1) resulted in lower levels of expression. The cell
cycle related level of expression was also seen in the transformed cells. Similar results to those observed in the
in vitro ras transfected liver-derived cell lines were obtained from in vivo AFB1-induced rat hepatoma cell
lines. These results demonstrate that continuously dividing rat liver-derived cell lines have higher levels of
expression of c-myc protein than non-dividing, freshly isolated hepatocytes, and that there is no further
elevation in the levels observed when these cell lines are transformed. In some cases decreased levels can result
from malignant transformation.
An alteration in the expression of cellular oncogenes has
been found to accompany neoplastic transformation, both in
vivo and in vitro. Most of the oncogenes for which the
mechanism of action has been examined have been shown to
be involved in the processes controlling cell division and
differentiation. Alteration of oncogene expression
presumably leads to the deregulation of these processes,
which results in the altered growth properties of the
neoplastic cell.
There is evidence that the c-myc oncogene has a role in
cell proliferation. The c-myc protein is associated with the
nucleus (Evan & Hancock, 1986) and DNA synthesis is
inhibited by antibodies to the c-myc protein (Studzinski et
al., 1986). In an in vivo malignancy there are many
differences from normal tissues including uncontrolled cell
proliferation, invasiveness and the property to metastasise,
and frequently a heterogenous population of cells is present.
Therefore, in the present study, cells with well defined
characteristics were used to study the expression of c-myc
protein in primary hepatocytes and both transformed and
untransformed rat liver-derived cell lines.
In previously reported studies on rat liver, the c-myc
m-RNA has been found to be increased following partial
hepatectomy (Makino et al., 1984a; Thompson et al., 1986),
and is also increased in primary hepatocytes in culture in
response to growth factors (Kruiger et al., 1986). Following
the administration of hepatocarcinogens it has been found to
be elevated in the tumorous portions of liver of rats as
compared to the non-tumorous portion (Makino et al.,
1984b; Cote et al., 1985). However, here again, because of
the heterogeneous nature of the tissue and the possible
presence of both toxic and preneoplastic changes in liver
which is apparently 'normal', it is difficult to define precisely
the cellular composition of the tissues.
The present study was carried out using cells at various
stages of transformation to examine possible correlations
between those stages and the expression of c-myc protein.
Cells used in the study were freshly isolated hepatocytes,
immortalised but untransformed rat liver-derived cell lines,
their transformed derivatives obtained by transfection with
ras oncogenes or by treatment with AFB, in vitro and cell
lines derived from AFB1-induced primary hepatomas. A
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flow cytometric technique was used to detect and quantitate
the c-myc protein and was also able to assess levels of the
protein at different phases of the cell cycle. This provided
information on the cell cycle dependent kinetics of the
expression of the protein. Fixed cells were used and no
attempts made to distinguish between nuclear and
cytoplasmic expression of the protein.
Materials and methods
Tissue culture and cell lines
Freshly isolated hepatocytes were obtained by perfusing rat
liver obtained from young adult male Fischer rats (200-225 g
body weight) (Berry & Friend, 1962). Cells were fixed
immediately after isolation in 50% methanol in PBS.
Immortalised but untransformed rat liver-derived epithelial
cell lines (BL8 and BL9) were previously derived by
spontaneous immortalisation of cells from primary cultures
of hepatocytes (Manson et al., 1981). These are continuously
dividing cell lines but are contact inhibited, non-tumorigenic
in nude mice and do not show anchorage independent
growth. On transformation of BL8 cells either by
transfection with cloned ras oncogenes (Sinha et al., 1986) or
by aflatoxin B1 (AFB1) in vitro (Sinha et al., 1987a) these
cell lines show the induction of biochemical markers specific
for liver cell transformation (elevated gamma-glutamyl
transferase and glutathione S-transferase P levels) and can
reproduce a range of the phenotype paralleling that seen in
experimental rat hepatomas in vivo (Sinha et al., 1987b). On
cotransfection with ras oncogene along with G418 resistant
markers, a number of G418 resistant cell lines were obtained
which are untransformed, presumably because of the
inappropriate or inadequate expression of the oncogene
product. These untransformed derivatives of the cell line
BL8 were cloned and acted as further controls for their
transformed counterparts. Other cells used in this study were
two lines derived in this laboratory from in vivo AFB1
induced rat liver tumours (JBI and BLIO) and the Morris
Hepatoma (HTC) cell line (Morris et al., 1978) which is
known to possess high expression of c-myc.
Staining for c-myc-product
Antibody to c-myc (MYC 1-6E10) was kindly made
available by G. Evan (MRC, Cambridge). This is a
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monoclonal antibody (Evan et al., 1985) to the 62 kD
protein initially raised in Balb/C mice against a synthetic
peptide. The flow cytometric assay for c-myc was essentially
based on the procedure described by Watson et al. (1985).
Replicate samples of cultured cells in log phase were
detached by trypsin/EDTA (0.05% w/v, 0.5 mM in PBS),
washed in phosphate buffered saline (PBS) and fixed in 50%
methanol in PBS. Fixed cells were stored at 4°C for periods
of up to 2 weeks. About 1 x 106 cells were then resuspended
in 6ml PBS and aliquots dispensed into Eppendorftubes. Cells
were centrifuged for 4min and the supernatant was
aspirated. The cell pellet was then resuspended in 10 1l of the
antibody (1Ox concentrated hybridoma culture supernatant)
at dilutions of 1:10, 1:31.6, 1:100 and 1:316 while PBS was
used for the control. Cells were incubated with the antibody
for 60min at room temperature and washed once with 0.5 ml
PBS. Cells were then incubated with rabbit antimouse
antibody conjugated to FITC (Dacopatts Immuno) diluted
1:20 in PBS. Cells were incubated with the second antibody
for 60min, washed with PBS and resuspended in 0.5 ml of
PBS containing propidium iodine (PI) (0.05 mgml-1) and
RNase. Each series of samples had two controls, cells
stained with PI alone and cells containing PI and the second
antibody alone. Flow cytometry for such cells has been
described by Watson et al. (1985). The quantitation of c-myc
protein by this method is semi-quantitative and is expressed
in arbitrary fluorescence units. This semi-quantitation
permits valid comparisons to be made between levels in the
different cell lines. The red fluorescence, due to PI staining
of the DNA, indicated the DNA status of the individual cells
and hence the position in the cell cycle, while the specific c-
myc staining was indicated by green fluorescence due to the
presence of the FITC-labelled second antibody. Mean





















Figure 1 c-myc specific green fluorescence in three samples of
freshly isolated hepatocytes (isolated points A, 0 and V) and in
the two rat liver-derived cell lines BL8 (M-M) and BL9
(0-0). The diploid (2n) and tetraploid/binucleate (4n) popula-
tions of rat hepatocytes are represented, while for the cell lines
the c-myc levels are for the G1, S and G2 points of the cell cycle.
Results
The expression of c-myc protein by the cells was assayed
using a monoclonal antibody to the protein as the primary
antibody, an FITC-conjugated second antibody and the
Cambridge MRC multiparameter flow cytometer (Watson,
1987). The median green fluorescence channel was used to
quantify the amount of c-myc in the individual samples.
Fluorescence levels were measured in all samples at different
concentrations of antibody and the optimum concentrations
of the antibody determined for use in the quantification.
Freshly isolated hepatocytes had extremely low levels of
c-myc protein. On the basis of the PI stain, three populations
of cells were observed on the red fluorescence axis which
were identified as diploid, tetraploid and diploid binucleates
(which could not be distinguished from mononucleate
tetraploids) and octaploid. Adult rat hepatocytes have an
extremely low mitotic index and S-phase cells were not
detected (Figure 1).
The two immortalised but untransformed rat liver cell
lines BL8 and BL9 expressed different levels of c-myc
protein, both of which were considerably higher than those
present in three samples of freshly isolated hepatocytes
(Figure 1). One of the tumorigenic derivatives of the BL8
cells (Figure 2) transfected with activated ras oncogenes and
two BL8 derived cell lines transfected with PSV2 neo Ha-ras
(Sinha et al., 1986) and exhibiting neomycin resistance but
non-tumorigenic (Figure 2) had c-myc levels which were
similar. The BL8 derived cell line transformed in vitro with
activated AFB1 had lower levels of c-myc expression (Figure
2). Cell lines JB1 and BL1O (from in vivo tumours) again
expressed c-myc at a similar level to that seen in the BL8
parent line. HTC, the Morris hepatoma cell line which is
known to have a high level of c-myc expression, exhibited


























Figure 2 c-myc specific green fluorescence levels in transformed
and untransformed cell lines. (I) BL8 cell line (0) and two
untransformed derivatives obtained after transfection and selec-
tion for antibiotic resistance (-, 0). (II) Transformed derivatives
of BL8 obtained by transfection with Ha-ras genes (0) or by
treatment with aflatoxin B1 (A\). (III) Cell lines obtained from
the in vivo hepatomas, Morris hepatoma cell line HTC (U), and
aflatoxin Bi induced hepatomas JB1 (A) and BLIO (0). The
results are means of replicate samples. There was variation
between the replicate samples of the individual cell lines but in
all experiments the same comparative expression between the cell
lines was observed.
(Figure 2). In all the cell lines, c-myc levels were cell cycle
dependent, increasing from GI through S to G2. In general,
within a given cell line, the c-myc levels had a linear
relationship with the amount of DNA in any phase of the
cell cycle.676 S. SINHA et al.
Discussion
It is possible to observe the distinction between cell
proliferation and transformation in in vitro systems much
more clearly than in most in vivo models of carcinogenesis.
The experimental in vitro phenotypic indicators of cell
transformation, e.g. anchorage independent growth, loss of
contact inhibition and tumorigenicity in nude mice, are able
to distinguish a transformed cell from an immortalised or
dividing cell, especially when taken in conjunction with each
other. The cell lines used in this study included derivatives of
the BL8 cell line which had been transformed by N-ras and
Ha-ras as well as by AFB1 in vitro. The AFB1 transformed
cell line has been shown to contain an activated Ha-ras gene,
and the cell lines JBI and BL0 from in vivo tumours
contain activated N-ras genes (Sinha et al., 1987b). There
was a variation in the c-myc content between the individual
cell lines, and the reasons for this are not clear. c-myc
expression levels were found to be higher in all the
continuously dividing cell lines as compared to the non-
dividing hepatocytes. The transformed cell lines did not have
elevated c-myc levels compared with untransformed cells and
in one case of cell transformation (with activated AFB1)
there appeared to be reduced expression of the c-myc
protein. Although the hepatoma cell line HTC is a known c-
myc over-producer, one of the untransformed derivatives of
the BL8 was found to have levels of the protein approaching
those of the HTC line. Using homogenous cell populations
as in the present study, it is easier to examine the association
between the c-myc oncogene levels and other growth
properties.
A cell cycle dependent change in the levels of the c-myc
gene product was also clearly demonstrated in the study, the
levels increasing from GI through S to G2 and closely
paralleling the increase in the DNA content of the cell line
being studied. In contrast the levels in non-dividing
hepatocytes were found to be low even in those populations
possessing higher ploidies. The cell cycle dependent increase
in the c-myc values in the case of the liver-derived epithelial
cell lines differs from the observations on fibroblastic 3T3
cells (Rabbits et al., 1985). The reasons for this difference
between the two cell lines are not known. The results of this
study, considered in the light of two stages believed to be
involved in the chemically induced malignant transformation
of cells, namely immortalisation and oncogene activation,
strongly support the involvement of elevated myc expression
in the former process but not in the latter. It is intended to
examine this parameter in the in vivo situation, which may
help to determine the sequence in which the 'mutational'
events occur in in vivo aflatoxin-induced carcinogenesis in rat
liver.
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